New glasses could help Kids' eyesight stop getting worse

NCT ID NCT05562622

Ongoing Disease control Sponsor: SightGlass Vision, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This trial tests whether special spectacle lenses called Diffusion Optics Technology (DOT) lenses can slow the progression of nearsightedness (myopia) in Chinese children aged 6 to 13. Over 12 months, 195 children will wear either the DOT lenses or standard single-vision lenses. The main goal is to see if the DOT lenses reduce the lengthening of the eye, which is linked to worsening myopia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Diffusion Optics Technology (DOT) spectacle lenses
What this could lead to: If successful, these lenses could offer a simple, non-invasive way to slow the progression of nearsightedness in children, reducing the need for stronger prescriptions over time.
What could go wrong: This is a 12-month study with 195 children, so results are still early. The lenses may not work for everyone, and long-term benefits beyond one year are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for JUVENILE MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

JUVENILE MYOPIA MYOPIA

Contacts and locations

Locations

Aier Eye Hospital

Changsha, China
Fudan University EENT

Shanghai, China
Tianjin Eye Hospital

Tianjin, China
West China Hospital

Chengdu, China
Zhongshan Ophthalmic Center

Guangzhou, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.